Global Pharmaceuticals & Biotech Healthy potentially undervalued

Trulieve Cannabis

Market Cap: US$2.0b

Operates as a cannabis retailer in the United States.

High Tide

Market Cap: CA$297.9m

Engages in the cannabis retail business in Canada, the United States, and internationally.

United Therapeutics

Market Cap: US$22.3b

Engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally.

Hypera

Market Cap: R$14.9b

Operates as a pharmaceutical company in Brazil.

CorMedix

Market Cap: US$641.5m

A biopharmaceutical company, focuses on developing and commercializing therapeutic products for life-threatening diseases and conditions in the United States.

UCB

Market Cap: €41.5b

A biopharmaceutical company, develops products and solutions for people with neurology and immunology diseases worldwide.

Vetoquinol

Market Cap: €825.2m

A veterinary pharmaceutical company, engages in designing, developing, and selling of veterinary drugs and non-medicinal products for cattle, pigs, dogs, and cats in Europe, the Americas, and the Asia Pacific region.

Supernus Pharmaceuticals

Market Cap: US$2.8b

A biopharmaceutical company, engages in the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States.

Green Thumb Industries

Market Cap: CA$2.2b

Manufactures, distributes, markets, and sells of cannabis products for medical and adult-use in the United States.

Elanco Animal Health

Market Cap: US$11.8b

An animal health company, innovates, develops, manufactures, and markets products for pets and farm animals worldwide.

Yunnan Baiyao GroupLtd

Market Cap: CN¥88.0b

Engages in the sale of pharmaceuticals, medicinal materials, health and daily chemical products in China.

Hugel

Market Cap: ₩2.6t

Develops and manufactures biopharmaceuticals in South Korea and internationally.

Bavarian Nordic

Market Cap: DKK 16.0b

Develops, manufactures, and supplies life-saving vaccines.

Virbac

Market Cap: €2.8b

Manufactures and sells a range of products and services for companion and farm animals in Europe, North America, Latin America, East Asia, India, Africa, the Middle East, the United States, Brazil, and the Pacific.

Diaceutics

Market Cap: UK£116.3m

A diagnostic commercialization company, provides data, data analytics, and implementation services for pharma and biotech companies.

Prestige Consumer Healthcare

Market Cap: US$2.4b

Develops, manufactures, markets, distributes, and sells over the counter (OTC) health and personal care products in North America, Australia, and internationally.

ANI Pharmaceuticals

Market Cap: US$1.7b

A biopharmaceutical company, develops, manufactures, and markets branded and generic pharmaceutical products in the United States and internationally.

Dong-E-E-Jiao

Market Cap: CN¥30.9b

Engages in the research, development, production, and sale of donkey-hide gelatin and related products in China and internationally.

Fennec Pharmaceuticals

Market Cap: US$398.0m

Operates as a commercial stage biopharmaceutical company in the United States.

Journey Medical

Market Cap: US$211.4m

A commercial-stage pharmaceutical company that focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States.

Cresco Labs

Market Cap: CA$493.2m

Cresco Labs Inc. cultivates, manufactures, and sells retail and medical cannabis products in the United States and Germany.

Decibel Cannabis

Market Cap: CA$72.1m

An integrated cannabis company, engages in the cannabis cultivation, processing, and sale of cannabis flower products in Canada.

Duopharma Biotech Berhad

Market Cap: RM 1.2b

Researches, develops, manufactures, markets, sells, imports, and distributes pharmaceutical products and medicines in Malaysia and internationally.

Amoy Diagnostics

Market Cap: CN¥7.3b

Engages in research and development, production, sale, and supporting services of tumor precision medical diagnostic products in China and internationally.

China Resources Jiangzhong PharmaceuticalLtd

Market Cap: CN¥15.5b

Engages in the manufacture of pharmaceutical products in China.

Dong-A ST

Market Cap: ₩357.1b

Develops, manufactures, and markets pharmaceutical products in South Korea and internationally.

Dermapharm Holding

Market Cap: €2.0b

Manufactures and sells off-patent branded pharmaceutical products in Germany, Italy, France, Austria, Switzerland, Spain, Portugal, the Netherlands, Croatia, Poland, Ukraine, the United States, and China.

Laboratorios Farmaceuticos Rovi

Market Cap: €3.1b

Manufactures, sells, and markets pharmaceutical products in Spain, European Union, OECD countries, and internationally.

China Resources Pharmaceutical Group

Market Cap: HK$30.2b

An investment holding company, engages in the manufacture, distribution, and retail of pharmaceutical and other healthcare products in Mainland China and internationally.

Tianjin Ringpu Bio-TechnologyLtd

Market Cap: CN¥8.1b

Engages in the research and development, production, and sale of veterinary raw materials, pharmaceutical preparation, functional additives, and veterinary biological products.

Curaleaf Holdings

Market Cap: CA$3.5b

Engages in the retail and wholesale of cannabis products in the United States and internationally.

Cellectis

Market Cap: €215.2m

A clinical stage biotechnological company, develops products based on gene-editing with a portfolio of allogeneic chimeric antigen receptor T-cells product candidates in the field of immuno-oncology and gene therapy product candidates in other therapeutic indications.

Protara Therapeutics

Market Cap: US$230.5m

A clinical-stage biopharmaceutical company, engages in advancing transformative therapies for the treatment of cancer and rare diseases.

H. Lundbeck

Market Cap: DKK 40.4b

Engages in the research, development, manufacturing, and commercializing pharmaceuticals for the treatment of psychiatric and neurological disorders in Europe, United States, and internationally.

Verastem

Market Cap: US$617.6m

A development-stage biopharmaceutical company, focuses on developing and commercializing drugs for the treatment of cancer in the United States.

Amphastar Pharmaceuticals

Market Cap: US$922.2m

A bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France.